Directional Asset Management Invests $545,000 in Corteva, Inc. $CTVA

Directional Asset Management purchased a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 8,125 shares of the company’s stock, valued at approximately $545,000.

Several other institutional investors have also modified their holdings of CTVA. Perpetual Ltd boosted its stake in shares of Corteva by 78,688.5% during the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after acquiring an additional 2,612,459 shares in the last quarter. Pacer Advisors Inc. boosted its stake in shares of Corteva by 4,007.1% during the 3rd quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock worth $165,164,000 after acquiring an additional 2,382,715 shares in the last quarter. Amundi boosted its stake in shares of Corteva by 125.3% during the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after acquiring an additional 1,899,248 shares in the last quarter. Squarepoint Ops LLC boosted its stake in shares of Corteva by 423.6% during the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock worth $117,550,000 after acquiring an additional 1,406,199 shares in the last quarter. Finally, Man Group plc boosted its stake in shares of Corteva by 16,474.3% during the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company’s stock worth $87,522,000 after acquiring an additional 1,286,317 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

CTVA stock opened at $79.66 on Friday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock’s 50 day moving average price is $80.00 and its 200 day moving average price is $71.49. The firm has a market cap of $53.48 billion, a P/E ratio of 50.41, a PEG ratio of 2.72 and a beta of 0.68.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the prior year, the company earned $0.32 EPS. Corteva’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 3.62 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were issued a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s payout ratio is 45.57%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on CTVA shares. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Wells Fargo & Company upped their target price on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday. Jefferies Financial Group upped their target price on Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, March 2nd. Finally, Argus upped their target price on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, March 31st. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $84.90.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.15% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.